IRIS
BUTTARI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.969
EU - Europa 1.242
AS - Asia 887
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
AF - Africa 2
Totale 15.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.953
SG - Singapore 374
IT - Italia 324
KR - Corea 237
IE - Irlanda 231
CN - Cina 179
DE - Germania 155
UA - Ucraina 136
GB - Regno Unito 89
FR - Francia 66
PL - Polonia 55
SE - Svezia 44
HK - Hong Kong 38
FI - Finlandia 36
RU - Federazione Russa 33
BE - Belgio 19
CZ - Repubblica Ceca 18
CA - Canada 13
IN - India 11
JP - Giappone 11
EU - Europa 9
UZ - Uzbekistan 9
BR - Brasile 8
RO - Romania 8
HR - Croazia 5
IR - Iran 5
SA - Arabia Saudita 5
AU - Australia 4
GR - Grecia 4
NL - Olanda 4
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
DM - Dominica 3
MY - Malesia 3
TR - Turchia 3
AR - Argentina 2
DK - Danimarca 2
ES - Italia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 15.131
Salva come PNG Salva come JPEG
Città #
Wilmington 3.509
Houston 3.271
Woodbridge 2.787
Chandler 537
Fairfield 511
Singapore 325
Ann Arbor 287
Ashburn 224
Dublin 200
Seattle 198
Cambridge 172
New York 153
Medford 131
Rome 118
Jacksonville 94
Santa Clara 85
Dearborn 80
Lawrence 63
Kraków 52
Zhengzhou 45
Beijing 39
Munich 29
Palo Alto 24
London 23
San Diego 23
Norwalk 22
Philadelphia 21
Milan 20
Brussels 19
Moscow 19
Southern 19
Hong Kong 18
Brno 17
Roebling 17
Menlo Park 16
Redwood City 15
Nanjing 13
Arosio 12
Seoul 12
Naples 11
Guangzhou 9
Tokyo 9
Center 8
Colorado Springs 8
Inverigo 8
Falls Church 7
Hefei 7
Helsinki 7
Kunming 7
Mountain View 7
Nanchang 7
San Francisco 7
San Jose 7
Shanghai 7
São Paulo 7
Toronto 7
Detroit 6
Hangzhou 6
Bari 5
Bologna 5
Catania 5
Frankfurt am Main 5
Hounslow 5
Lappeenranta 5
Redmond 5
Turin 5
Verona 5
Atlanta 4
Chongqing 4
Jinan 4
Mülheim 4
New Bedfont 4
Palermo 4
Phoenix 4
Pune 4
Riyadh 4
Bogotá 3
Chennai 3
Chicago 3
Fuzhou 3
Hanover 3
Hebei 3
Kuala Lumpur 3
Paris 3
Roseau 3
Salo 3
Târgu Mureş 3
University Park 3
Warsaw 3
Abuja 2
Acton 2
Alessandria 2
Amsterdam 2
Ancona 2
Athens 2
Boardman 2
Brooklyn 2
Cagliari 2
Chengdu 2
Chiswick 2
Totale 13.504
Salva come PNG Salva come JPEG
Nome #
Neurophysiology of synaptic functioning in multiple sclerosis 510
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 476
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 462
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 453
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 450
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 449
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 437
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 434
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 416
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 413
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 408
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 407
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 401
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 399
Epstein-Barr virus genetic variants are associated with multiple sclerosis 397
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 387
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study 379
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 373
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 367
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 361
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 359
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 352
Reversible hyporegenerative anemia during natalizumab treatment 342
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 333
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 322
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study 320
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 300
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 295
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 289
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 279
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 276
Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis 261
TRPV1 channels regulate cortical excitability in humans 261
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 242
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 235
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 216
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 155
Multiple Sclerosis: kFLC index values related to gender 135
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 130
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 128
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 91
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 86
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 85
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 83
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 81
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 68
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 67
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 65
Interleukin-1β alters hebbian synaptic plasticity in multiple sclerosis 64
A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset 63
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 59
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 58
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential 53
Age at disease onset associates with oxidative stress, neuroinflammation, and impaired synaptic plasticity in relapsing-remitting multiple sclerosis 52
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 50
A single nucleotide ADA genetic variant is associated to central inflammation and clinical presentation in MS: implications for cladribine treatment 48
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 48
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab 48
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 46
A large family with p.Arg554His mutation in ABCD1: clinical features and genotype/phenotype correlation in female carriers 45
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 43
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 43
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 43
Decipher non-canonical SPAST splicing mutations with the help of functional assays in patients affected by spastic paraplegia 4 (SPG4) 39
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 39
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 34
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 32
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 30
Osteopontin Is Associated with Multiple Sclerosis Relapses 29
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 28
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 26
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 26
Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis 25
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 25
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 24
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 23
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 23
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 20
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 14
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 11
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 10
Totale 15.456
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.352 0 0 264 374 315 431 397 354 376 316 260 265
2020/20212.662 251 284 251 294 311 278 455 291 73 70 75 29
2021/2022706 36 33 16 40 3 127 32 34 77 89 33 186
2022/20231.327 135 115 118 206 77 283 90 64 103 14 61 61
2023/2024536 85 20 24 29 39 121 28 40 25 26 21 78
2024/2025687 88 430 169 0 0 0 0 0 0 0 0 0
Totale 15.456